American Society For Transplantation & Cellular Therapy
EIN: 521850793 · Chicago, IL · NTEE: H20Z
| Metric | Value |
|---|---|
| Total Revenue | $8.7M |
| Total Expenses | $8.3M |
| Net Assets | $8.8M |
Is American Society For Transplantation & Cellular Therapy Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About American Society For Transplantation & Cellular Therapy
American Society For Transplantation & Cellular Therapy (EIN: 521850793) is a nonprofit organization based in Chicago, IL, classified under NTEE code H20Z. The organization reported total revenue of $8.7M and total assets of $13.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of American Society For Transplantation & Cellular Therapy's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
American Society For Transplantation & Cellular Therapy is a mid-size nonprofit that has been operating for 32 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 8.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $8.1M |
| Total Expenses | $8.3M |
| Surplus / Deficit | $-212,040 |
| Total Assets | $12.0M |
| Total Liabilities | $3.2M |
| Net Assets | $8.8M |
| Operating Margin | -2.6% |
| Debt-to-Asset Ratio | 26.4% |
| Months of Reserves | 17.3 months |
Financial Health Grade: B
In 2023, American Society For Transplantation & Cellular Therapy reported a deficit of $212K with expenses exceeding revenue, holds 17.3 months of operating reserves (strong position), has a debt-to-asset ratio of 26.4% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), American Society For Transplantation & Cellular Therapy's revenue has grown at a compound annual growth rate (CAGR) of 8.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +7.2% | +20.9% | +8.5% |
| 2022 | +36.9% | +43.4% | -3.5% |
| 2021 | -4.2% | +3.5% | +18.9% |
| 2020 | +6.2% | +6.1% | +16.3% |
| 2019 | +22.0% | +14.1% | +26.8% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 3000 |
| IRS Ruling Date | 1994 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for American Society For Transplantation & Cellular Therapy has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates American Society For Transplantation & Cellular Therapy with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $212K, with expenses exceeding revenue.
- Debt-to-asset ratio: 26.4%.
Frequently Asked Questions about American Society For Transplantation & Cellular Therapy
Is American Society For Transplantation & Cellular Therapy a legitimate charity?
Based on AI analysis of IRS 990 filings, American Society For Transplantation & Cellular Therapy (EIN: 521850793) insufficient data. 0 red flags identified, 0 strengths noted.
How does American Society For Transplantation & Cellular Therapy spend its money?
Detailed spending breakdown data is not yet available for American Society For Transplantation & Cellular Therapy. Check back for updated IRS 990 analysis.
Are donations to American Society For Transplantation & Cellular Therapy tax-deductible?
American Society For Transplantation & Cellular Therapy is registered as a tax-exempt nonprofit (EIN: 521850793). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is American Society For Transplantation & Cellular Therapy located?
American Society For Transplantation & Cellular Therapy is headquartered in Chicago, Illinois and files with the IRS under EIN 521850793. It is classified under NTEE code H20Z.
How many years of IRS 990 filings does American Society For Transplantation & Cellular Therapy have?
American Society For Transplantation & Cellular Therapy has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $8.7M in total revenue.
Filing History
IRS 990 filing history for American Society For Transplantation & Cellular Therapy showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), American Society For Transplantation & Cellular Therapy's revenue has grown by 179.1%, moving from $2.9M to $8.1M. Total assets increased by 368.6% over the same period, from $2.6M to $12.0M. Total functional expenses rose by 209.1%, from $2.7M to $8.3M. In its most recent filing year (2023), American Society For Transplantation & Cellular Therapy reported a deficit of $212K, with expenses exceeding revenue. The organization holds $3.2M in liabilities against $12.0M in assets (debt-to-asset ratio: 26.4%), resulting in net assets of $8.8M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $8.1M | $8.3M | $12.0M | $3.2M | — | — |
| 2022 | $7.6M | $6.9M | $11.0M | $3.2M | — | View 990 |
| 2021 | $5.5M | $4.8M | $11.4M | $1.7M | — | View 990 |
| 2020 | $5.8M | $4.6M | $9.6M | $902K | — | View 990 |
| 2019 | $5.4M | $4.4M | $8.3M | $1.4M | — | View 990 |
| 2018 | $4.5M | $3.8M | $6.5M | $1.5M | — | View 990 |
| 2017 | $4.1M | $3.9M | $6.2M | $1.4M | — | View 990 |
| 2016 | $3.3M | $2.9M | $5.5M | $1.4M | — | View 990 |
| 2015 | $3.6M | $3.1M | $5.0M | $1.5M | — | View 990 |
| 2014 | $2.9M | $2.5M | $4.1M | $1.0M | — | View 990 |
| 2013 | $3.0M | $2.5M | $3.6M | $979K | — | View 990 |
| 2012 | $3.0M | $2.4M | $3.3M | $1.1M | — | View 990 |
| 2011 | $2.9M | $2.7M | $2.6M | $917K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $8.1M, expenses of $8.3M, and assets of $12.0M (revenue +7.2% year-over-year).
- 2022: Revenue of $7.6M, expenses of $6.9M, and assets of $11.0M (revenue +36.9% year-over-year).
- 2021: Revenue of $5.5M, expenses of $4.8M, and assets of $11.4M (revenue -4.2% year-over-year).
- 2020: Revenue of $5.8M, expenses of $4.6M, and assets of $9.6M (revenue +6.2% year-over-year).
- 2019: Revenue of $5.4M, expenses of $4.4M, and assets of $8.3M (revenue +22.0% year-over-year).
- 2018: Revenue of $4.5M, expenses of $3.8M, and assets of $6.5M (revenue +9.9% year-over-year).
- 2017: Revenue of $4.1M, expenses of $3.9M, and assets of $6.2M (revenue +21.3% year-over-year).
- 2016: Revenue of $3.3M, expenses of $2.9M, and assets of $5.5M (revenue -7.5% year-over-year).
- 2015: Revenue of $3.6M, expenses of $3.1M, and assets of $5.0M (revenue +25.7% year-over-year).
- 2014: Revenue of $2.9M, expenses of $2.5M, and assets of $4.1M (revenue -2.6% year-over-year).
- 2013: Revenue of $3.0M, expenses of $2.5M, and assets of $3.6M (revenue -1.2% year-over-year).
- 2012: Revenue of $3.0M, expenses of $2.4M, and assets of $3.3M (revenue +2.8% year-over-year).
- 2011: Revenue of $2.9M, expenses of $2.7M, and assets of $2.6M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for American Society For Transplantation & Cellular Therapy:
Data Sources and Methodology
This transparency report for American Society For Transplantation & Cellular Therapy is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.